Medical Devices Canada

Canada Orthobiologics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Canada Orthobiologics Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Canada · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $561.3 Mn Placeholder estimate
Estimate 2025 $595.5 Mn 8.8% of the global market
Projected 2034 $1.01 Bn 70.4% Adds $419.2 Mn over 9 forecast years
CAGR 2025–2034 6.1% Faster than 15% of 173 Medical Devices markets here
Key players 5
  • Canada is 8.83% of the global market.
  • In North America, the largest is US at $2.95 Bn.
  • Fastest growing: Canada (this report) at 6.1% a year.
  • Canada ranks 2nd of 2 by size in North America.

Market size projection

Canada

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$419.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Orthobiologics Market market size by year, Canada
YearMarket sizeChange that yearSince 2025
2024 (estimate) $561.3 Mn — —
2025 (base) $595.5 Mn +$34.2 Mn —
2026 (forecast) $631.8 Mn +$36.3 Mn +6.1%
2027 (forecast) $670.4 Mn +$38.5 Mn +12.6%
2028 (forecast) $711.3 Mn +$40.9 Mn +19.4%
2029 (forecast) $754.7 Mn +$43.4 Mn +26.7%
2030 (forecast) $800.7 Mn +$46.0 Mn +34.5%
2031 (forecast) $849.5 Mn +$48.8 Mn +42.7%
2032 (forecast) $901.4 Mn +$51.8 Mn +51.4%
2033 (forecast) $956.3 Mn +$55.0 Mn +60.6%
2034 (forecast) $1.01 Bn +$58.3 Mn +70.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Canada Orthobiologics Market Analysis at a glance
Market size, 2025$595.5 Mn placeholder estimate
Forecast, 2034$1.01 Bn placeholder estimate
Growth (CAGR), 2025–20346.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersMedtronic, Stryker, Zimmer Biomet Holdings, Inc., Bioventus, Orthofix Medical (see all)
Regulator in CanadaHealth CanadaSource: Health Canada. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Canada Orthobiologics Market Analysis Executive Summary

Orthobiologics use natural substances such as bone grafts, growth factors and cells to help bones and soft tissue heal.

Key segments of the orthobiologics market include product (Bone Grafts, Platelet-Rich Plasma and Stem Cells) and application (Spinal Fusion, Trauma and Sports Injuries).

Bar chart: Canada Orthobiologics market size, 2024–2034, placeholder estimates. $561.3 Mn in 2024, $595.5 Mn in 2025 and $1.01 Bn in 2034, 6.1% CAGR.
Canada Orthobiologics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Canada Orthobiologics Market Dynamics

Market Growth Drivers

An ageing and more active population, more sports injuries, rising obesity and better implants and procedures are driving the orthobiologics market.

Opportunity

Same-day joint surgery, robotics, smart implants and biologic treatments give the orthobiologics market room to grow.

Market Restraints

High procedure costs, pricing pressure from hospitals, recalls and long recovery times hold back the orthobiologics market.

Competitive Landscape for Orthobiologics Market in Canada

The orthobiologics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Orthobiologics Market in Canada

Orthobiologics in Canada: rules, payment and health figures

Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.⁠[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.⁠[2] People aged 65 and over: 20.3% of people in 2025, the latest World Bank figure for Canada.⁠[3]

[1] Health Canada. Checked 14 Nov 2026.

[2] Health Canada. Checked 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how orthobiologics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Orthobiologics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Orthobiologics in context

Canada compared

  • People aged 65 and over: 20.3% of people (2025). World: 10.4% of people (2025).[1]
  • Health spending per person: 6,378 US$ per person (2024). World: 1,317 US$ per person (2023).[2]
  • Doctors: 2.82 per 1,000 people (2023). World: 1.86 per 1,000 people (2022).[3]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Orthobiologics market in Canada?
Placeholder estimate: about $595.5 Mn in 2025, rising to about $1.01 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Orthobiologics market in Canada growing?
Placeholder estimate: about 6.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Orthobiologics market report cover?
The report splits the market by product (Bone Grafts, Platelet-Rich Plasma, Stem Cells, Growth Factors and more), application (Spinal Fusion, Trauma, Sports Injuries, Joint Reconstruction) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Orthobiologics market?
Key players include Medtronic, Stryker, Zimmer Biomet Holdings, Inc., Bioventus and Orthofix Medical.
What is driving the Orthobiologics market?
An ageing and more active population, more sports injuries, rising obesity and better implants and procedures are driving the orthobiologics market.
Who regulates Orthobiologics in Canada?
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence. Source: Health Canada. Checked 14 Nov 2026.
How is healthcare paid for in Canada?
Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services. Source: Health Canada. Checked 14 Nov 2026.
What does World Bank report for Canada?
People aged 65 and over: 20.3% of people in 2025, the latest World Bank figure. Source: World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
How much research is published on Orthobiologics?
PubMed lists 563 papers on Orthobiologics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Canada

See all

Related on bones and joints

See the topic